Matthew is a qualified UK and European patent attorney. Matt has experience in drafting and prosecuting UK, European, and International patent applications, providing freedom-to-operate opinions, and advising clients on patent infringement and validity. The technical areas of Matt’s prosecution and opinion work include biochemistry, molecular biology, immunology, vaccines, antibody technology, and molecular medicine.
Matt graduated from the University of Oxford with a Masters degree in Molecular and Cellular Biochemistry, specialising in immunology. During his PhD at University College, London, he investigated the activation of dendritic cells and macrophages, and in particular, the intracellular signalling pathways regulating the activation, morphology, and survival of these cells. During this time, Matt developed a novel antibody-based assay for analysing and quantifying endocytic and phagocytic activity. Matt subsequently worked as a postdoctoral scientist in the Immunology Division of the National Institute for Medical Research, investigating the activation of intracellular signalling pathways in mouse macrophages using cellular, molecular biological, and transgenic technologies. During his post-doc, Matt also developed a novel antibody-based approach for measuring the activity of the Nf-kappaB pathway.
- Member of the Chartered Institute of Patent Attorneys
- Member of the European Institute of Patents